Skip to main content
. 2022 Apr 16;4(1):vdac055. doi: 10.1093/noajnl/vdac055

Table 2.

DLT Summary (n = 19)

Dose Levels (mg/m2/dose)a Treated Patients Evaluable Patients Patients With DLTs
Ribociclib Everolimus
Level 1 120 1.2 3 3 0
Level 2 170 1.2 3 3 0
Level 3 170 1.5 7 6 1b
Level 3, expansion cohort 170 1.5 6 6 0

Abbreviation: DLT, dose-limiting toxicities.

aRibociclib administered on days 1-21; everolimus on days 1-28, cycle 1.

bGrade 3 lung infection.